Saturday May 8th, 2021 11:44AM

Pfizer's posts $4.9B 1Q profit as vaccine strategy pays off

By The Associated Press
Related Articles
  Contact Editor

Selling vaccines during a pandemic has boosted Pfizer’s bottom line and proven that a strategy it embarked upon over a decade ago is now paying off handsomely.

The New York-based pharmaceutical giant reported Tuesday that it earned $4.9 billion in the first three months of the year and it dramatically raised its profit forecast for all of 2021 thanks to strong demand for its COVID-19 vaccine. The company, along with its German partner BioNTech, anticipate strong revenue from the vaccine and booster shots for the next three years.

Once viewed as a marketing machine for blockbuster treatments such as Viagra and Lipitor, Pfizer has transformed itself into a powerhouse for delivering drugs that treat cancer, rare diseases — and vaccines.

Pfizer on Tuesday almost doubled its sales projections for the COVID-19 vaccine this year, from $15 billion to roughly $26 billion. The partners expect to be able to deliver about 2.5 billion vaccine doses this year, including 300 million doses for the U.S., and already are prepping for what could become annual booster shots.

Pfizer got into the low-profile, low-profit vaccine field in 2009 when it acquired Wyeth and its then-experimental pneumococcal vaccine. That vaccine, Prevnar, which protects against ear, bloodstream and other pneumococcal infections, was approved by the U.S. the following year. It became the world’s most lucrative vaccine with annual sales of about $5 billion — once unheard of.

“Investors were skeptical of the Wyeth acquisition because vaccines were a sleepy area with lots of risk and rarely enough profit to justify spending money on them. Pfizer proved them wrong,” said Erik Gordon, a business professor at the University of Michigan.

Pfizer began developing more vaccines and building up expertise. Then in 2018 it began a partnership with BioNTech focused on creating a flu vaccine with a then-new technology called mRNA for short. This vaccine type uses genetic material rather than an inactivated virus to teach the immune system to produce antibodies if the real virus infects someone.

But while the flu vaccine was still in testing, the coronavirus hit and the companies turned on a dime to use the technology for a vaccine against it. Their vaccine has proven to be more than 90% effective and has rapidly won emergency approval in country after country while avoiding the manufacturing delays and safety questions stinging some rivals.

“Partnering with BioNTech was a stroke of genius or of good luck,” Gordon said.

Now the partners are testing a potential booster shot, and they continue to test the two-dose shot in new patient groups, including pregnant women, 12- through 15-year-olds and children from six months to 11 years old. They're also working on new vaccines formulations with a longer shelf life and less stringent requirements for deep freezing.

Pfizer also is testing both a pill and a different drug that’s injected as COVID-19 treatments.

Pfizer, which splits vaccine costs and profit with BioNTech, reported $3.46 billion in first-quarter sales in all but three countries; BioNTech will report the remaining revenue on May 10.

Some patient advocacy and consumer groups now accuse COVID-19 vaccine makers of profiteering as they’ve only pledged to stick to nonprofit prices until the pandemic emergency ends. Some want patents suspended to enable poor countries to get cheaper vaccines sooner.

On a conference call Tuesday, Pfizer noted its three price tiers for the vaccine, depending on each country’s financial situation. In the U.S., Pfizer charges $19.50 for each dose, far below what Prevnar and many other vaccines cost here.

Pfizer reported quarterly net income of $4.88 billion, or 86 cents per share, on Tuesday. That was up from $3.36 billion, or 60 cents per share, in the same period last year, when the global coronavirus pandemic began triggering lockdowns, and doctor visits, diagnostic tests and new prescriptions for other medicines dropped significantly.

Adjusted earnings jumped 48% to $5.26 billion, or 93 cents per share, far above the 79 cents Wall Street was expecting. Revenue was $14.58 billion, up 45% and also well above forecasts of $13.49 billion.

Sales of cancer drugs jumped 18% in the quarter and sales of medicines administered in hospitals rebounded 11% as patients got treatments delayed by hesitance to go to hospitals swamped with COVID-19 patients. Sales of clot preventer Eliquis jumped 26% to $1.64 billion.

Pfizer now expects full-year earnings in the range of $3.55 to $3.65 per share, up from $3.10 to $3.20 per share in February, and revenue in the range of $70.5 billion to $72.5 billion, up from $59.4 billion to $61.4 billion in the February forecast.


Follow Linda A. Johnson at https://twitter.com/LindaJ_onPharma

  • Associated Categories: Associated Press (AP), AP Health, AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care
© Copyright 2021 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Pfizer's posts $4.9B 1Q profit as vaccine strategy pays off
Selling vaccines during a pandemic has boosted Pfizer’s bottom line and proven that a strategy it embarked upon over a decade ago is now paying off handsomely
4:34PM ( 4 minutes ago )
Santorum's comments on Native Americans don't quiet critics
CNN analyst Rick Santorum went on the network to try and explain comments about Native Americans that have led to criticism, but he didn't appear to calm things down
4:18PM ( 20 minutes ago )
Hyundai recalls over 390K vehicles for possible engine fires
Hyundai is recalling over 390,000 vehicles in the U.S. and Canada for problems that can cause engine fires
4:14PM ( 23 minutes ago )
Associated Press (AP)
Biden aims for vaccinating 70% of adult Americans by July 4
President Joe Biden has set a new vaccination goal to deliver at least one dose to 70% of adult Americans by July Fourth
3:58PM ( 40 minutes ago )
LA, San Francisco improve for broader business reopening
Los Angeles and San Francisco have met state guidelines to move into the least-restrictive tier for businesses to reopen during the coronavirus pandemic
3:26PM ( 1 hour ago )
Madrid election centers on virus response, rise of far right
Madrid residents voted in droves for a new regional assembly in an election that tests the depths of resistance to virus lockdown measures and the divide between left-wing and right-wing parties
3:04PM ( 1 hour ago )
AP Health
EXPLAINER: Will Donald Trump return to Facebook?
Donald Trump will find out whether he gets to return to Facebook on Wednesday
3:43PM ( 54 minutes ago )
Pfizer's long range vaccine pursuits pay off
Pfizer is raising its 2021 revenue expectations amid the successful rollout of its COVID-19 vaccine and strong performances from many other medicines
3:21PM ( 1 hour ago )
Thunberg: 'We will not accept' giving up on limiting warming
Swedish teenage activist Greta Thunberg says it seems that those in power “have given up” on the 2015 landmark Paris climate deal to limit global warming to 1.5 degrees Celsius (2.7 degrees Fahrenheit) since pre-industrial times
3:20PM ( 1 hour ago )
AP Business
Technology shares sink broader market in afternoon trading
Stocks were solidly lower in afternoon trading Tuesday, dragged down by big technology companies like Apple and Google
1:37PM ( 3 hours ago )
Technology shares sink broader market in midday trading
Stocks were solidly lower in midday trading Tuesday, dragged down by big technology companies like Apple and Google
11:48AM ( 4 hours ago )
After an 11% profit spike, CVS outlook for 2021 grows rosy
CVS Health hiked its 2021 forecast and beat Wall Street’s first-quarter expectations as a growing insurance business countered hits the health care giant took from a weak cold and flu season
11:09AM ( 5 hours ago )
AP Business - Corporate News
Weak opening on Wall St led by healthcare, consumer stocks
Shares are  opening lower on Wall Street Tuesday led by the consumer discretionary and healthcare sectors
9:46AM ( 6 hours ago )
CVS take on 2021 gets rosier, profit jumps 11%
CVS Health beat Wall Street expectations and after releasing projections earlier this year that disappointed analysts, a new outlook Tuesday exceeds those levels
7:42AM ( 8 hours ago )
Pfizer ups expectations for the year
Pfizer is raising its revenue expectations for the year with a huge roll out of its COVID-19 vaccine as well as strong performances from other parts of its business
7:13AM ( 9 hours ago )
AP Business - Industries
The Latest: Alabama gov says pandemic "absolutely" managed
Declaring the COVID-19 pandemic “absolutely” managed despite lagging vaccinations, Alabama Gov. Kay Ivey says she will end a state health order meant to guard against the spread of an illness that has killed nearly 11,000 people statewide
5:38PM ( 23 hours ago )
Wall Street logs gains Monday on strong earnings
Stocks are closing solidly higher Monday as investors cheer a strong dose of positive earnings reports as well as economic data that showed the U.S. economy is growing
4:08PM ( 1 day ago )
The Latest: 2 Chinese vaccines may soon get approval for use
A top World Health Organization official says the organization is set to decide this week whether to approve two Chinese vaccines for emergency use against COVID-19
1:22PM ( 1 day ago )
AP Business - Health Care
Hyundai recalls over 390K vehicles for possible engine fires
Hyundai is recalling over 390,000 vehicles in the U.S. and Canada for problems that can cause engine fires
4:14PM ( 24 minutes ago )
Technology shares sink broader market although Dow has gain
Stocks are closing lower on Wall Street Tuesday, dragged down by big technology companies like Apple and Microsoft
4:14PM ( 24 minutes ago )
Nationals' Juan Soto reinstated from IL but won't start yet
The Washington Nationals have reinstated outfielder Juan Soto from the 10-day injured list, but last year’s NL batting champion will be limited to pinch-hitting duty for now
4:13PM ( 25 minutes ago )
Overpass collapse on Mexico City metro kills at least 24
Officials say 24 people were killed when an elevated section of Mexico City's metro collapsed as a train was traveling along it
4:10PM ( 28 minutes ago )
NFL draft drew 160,000 with protocols for limited attendance
Given that the nation remains in a pandemic, the NFL is more than satisfied with being able to attract 160,000 fans to the draft in Cleveland last week
4:01PM ( 37 minutes ago )